Akebia Therapeutics, Inc. - 8-K Filing
Nicholas Grund resigns as Senior Vice President and Chief Commercial Officer of Akebia Therapeutics effective November 6, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $AKBA